Actions of metformin and statins on lipid and glucose metabolism and possible benefit of combination therapy

Table 1 Overview of areas and focus of recent review articles about diabetes dyslipidemia and the corresponding focus area for each review is given

Area	Focus	References
Pathophysiology	No specific focus/general	Besseling and Hutten [153], Cederberg et al. [154], Checade et al. [155], Feingold and Grunfeld [156], Jaiswal et al. [157], Ng [158], Soran et al. [159], Schofield et al. [160], Verges[161], Wang et al. [162], Wu and Parhofer [2]
	Intestine	Arca [163], Tomkin and Owens [164]
	Liver	Arca et al. [165], Perry et al. [166], Taskinen and Boren [167]
Relation IR and lipids	–	Pagidipati et al. [168], Parhofer [169], Patel et al. [170], Perry et al. [166]
CV risk	–	Wang et al. [162]
Pharmacotherapy/treatment	Treatment of dyslipidemia	Cederberg et al. [154], Checade et al. [155], Dake and Sora [171], Halcox and Misra [172], Ng [158], Paneni and Cosentino [173], Schofield et al. [160], Szalat et al. [174], Wu and Parhofer [2]
Pharmacotherapy/treatment	Effects drugs on lipid and glucose metabolism	Ferrannini and DeFronzo [175], Soran et al. [159]
Complications	–	Balakumar [176], Chen and Tseng [177], Leon and Maddox [178], Paneni et al. [179]

ISSN: 1475-2840